Nicotine delivery of a menthol-flavored heat-not-burn tobacco product during directed use.

Jessica M YingstCandace BordnerShari HrabovskyAndrea L HobkirkNeil TrushinJohn P RichieJonathan Foulds

Published in: Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco (2023)

Menthol IQOS delivered a sufficient dose of nicotine perceived as satisfying by menthol cigarette smokers and it reduced craving with mild side effects. Menthol IQOS has potential to serve as a less harmful alternative for menthol cigarette smokers. The availability of modified risk products like IQOS should be considered by FDA's Comprehensive Plan for Tobacco and Nicotine Regulation.

Keyphrases

smoking cessation
depressive symptoms
physical activity
mental health
climate change
risk assessment
human health